BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
No open-market purchases or sales by BIO-TECHNE Corp insiders were filed in the last 90 days; 597 institutions reported holding it in 13F filings for Q2 2026, worth $12.3B in total; 3 superinvestors hold it, including Maverick Capital and Weitz Investment Management.
13F holders, Q4 2023
Institutional positions in BIO-TECHNE Corp as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 532
- +11 vs. Q3 2023
- Shares held
- 155.5M
- +3.30M (+2.2%) vs. Q3 2023
- Total value
- $12.0B
- +$1.64B (+15.8%) vs. Q3 2023
- New holders
- 82
- 210 more added
- Sold out
- 71
- 172 more reduced
9 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TECH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 597 | $12.3B |
| Q1 2026 | 585 | $9.29B |
| Q4 2025 | 586 | $10.1B |
| Q3 2025 | 577 | $8.84B |
| Q2 2025 | 556 | $8.16B |
| Q1 2025 | 578 | $9.52B |
| Q4 2024 | 577 | $11.3B |
| Q3 2024 | 564 | $12.4B |
| Q2 2024 | 573 | $11.2B |
| Q1 2024 | 556 | $11.2B |
| Q4 2023 | 532 | $12.0B |
| Q3 2023 | 530 | $10.4B |
| Q2 2023 | 529 | $12.3B |
| Q1 2023 | 552 | $11.0B |
| Q4 2022 | 547 | $12.4B |
| Q3 2022 | 536 | $10.8B |
| Q2 2022 | 551 | $12.9B |
| Q1 2022 | 556 | $16.3B |
| Q4 2021 | 576 | $19.1B |
| Q3 2021 | 567 | $17.8B |
| Q2 2021 | 512 | $16.5B |
| Q1 2021 | 470 | $14.0B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding BIO-TECHNE Corp; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Glass Jacobson Investment Advisors llc | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Perkins Coie Trust Co | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Pathstone Family Office, LLC | – | – | – | – | Not filed |
| Icon Wealth Partners, LLC | – | – | – | – | Not filed |
| First Republic Investment Management, Inc. | – | – | – | – | Not filed |
| Focus Financial Network, Inc. | – | – | – | – | Not filed |
| Advisor Partners II, LLC | – | – | – | – | Not filed |
| Bryn Mawr Trust Co | – | – | – | – | Not filed |
| Column Capital Advisors, LLC | – | – | – | – | Not filed |
| Sutton Wealth Advisors Inc. | – | – | – | – | Not filed |
| Steward Financial Group LLC | – | – | – | – | Not filed |